Cardiovascular Dysfunction in Children Exposed to Preeclampsia During Fetal Life

Zahra Hoodbhoy1, Nuruddin Mohammed2, Shafquat Rozi3

  • 1Department of Pediatrics and Child Health, The Aga Khan University, Karachi, Pakistan.

Insights

Children exposed to preeclampsia in utero show altered vascular function, including higher blood pressure and pulse-wave velocity. Early-onset preeclampsia is a key factor, highlighting the need for routine blood pressure screening in these children.

Area of Science:

  • Cardiovascular health
  • Developmental origins of health and disease (DOHaD)
  • Pediatric cardiology

Background:

  • The developmental origins of health and disease (DOHaD) hypothesis suggests early-life exposures impact long-term health.
  • Preeclampsia is a pregnancy complication that may affect fetal development.
  • Understanding the long-term cardiovascular impact of in utero preeclampsia exposure is crucial.

Purpose of the Study:

  • To investigate differences in cardiac and vascular structure and function in children exposed to preeclampsia in utero compared to those born to normotensive mothers.
  • To test the hypothesis that in utero preeclampsia exposure leads to altered cardiac and vascular outcomes in children.

Main Methods:

  • Retrospective cohort study of children aged 2-10 years, comparing those exposed to preeclampsia in utero with an unexposed group (n=80 each).
  • Assessment of myocardial morphology and function via echocardiography.
  • Measurement of carotid intima-media thickness and pulse-wave velocity.
  • Multivariate linear regression and subgroup analysis for early- vs. late-onset preeclampsia.

Main Results:

  • Children exposed to preeclampsia had a significantly higher prevalence of stage 1 systolic and diastolic hypertension compared to the unexposed group (22% vs 9% and 35% vs 19%, respectively; P=.01).
  • Exposed children exhibited higher pulse-wave velocity (0.42 ± 0.1 vs 0.39 ± 0.1; P=.03).
  • Early-onset preeclampsia was primarily associated with observed changes in blood pressure and pulse-wave velocity; no significant differences in cardiac morphology or function were found.

Conclusions:

  • In utero exposure to preeclampsia, particularly early-onset disease, impacts vascular function in children aged 2-10 years.
  • Routine blood pressure screening is recommended for children with in utero preeclampsia exposure.
  • The findings support the DOHaD hypothesis regarding cardiovascular programming after preeclampsia exposure.
Abstract

Related Concept Videos

Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
2.0K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.5K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.7K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
212